Design and Synthesis of Novel NSAIDs Class Acting as Anticancer Agents

Authors

  • Mona S. Kadah Chemistry Department, Faculty of Science, Al-Azhar University (Girls Branch), Nasr City, Cairo-Egypt, Tel: ++966508678586
  • A. A. Elhenawy Chemistry Department, Faculty of Science, Al-Azhar University (Boys Branch), Nasr City, Cairo-Egypt
  • Reda D. Abd Central Laboratory for Agricultural Climate, Agricultural Research Center, Ministry of Agriculture and Reclamation, Egypt
  • M. K. Hassanein Central Laboratory for Agricultural Climate, Agricultural Research Center, Ministry of Agriculture and Reclamation, Egypt

Keywords:

NASIDS, Coumarine, Anticancer agent, ADMET, DOCKIN and EAC.

Abstract

Several effective anticancer therapeutic drugs containing coumarin nucleus. Thus, some coumarin derivatives 3-22

References

N.C. Nicolaides Fylaktakidou, E. Litinas, D. Hadlipavlou-Litina,

D. N. Nicolaides, K. C. Fylaktakidou, K. E. Litinas ,D. Hadjipavlou-Litina,

R. Czerpack,S. Skolska, Med. Dosw.

L. Jund, J.Corse, A. S. King, H.Bayne, K .Mihrag,

S. L. El-Ansary, E. I .Aly, M. A. Halem, Egypt. J. Pharm. Sci. 33, 379, 1992.

B.Nair, and R. Taylor-Gjevre,

A.A.Elhenawy, M. A. El-Gazzar1 and A. M. Seliem, Global Journal of Chemistry, 2(1), 45-50, 2015

A.A.Elhenawy, M. A. El-Gazzar1 and H. M. Mohmmed, Chemistry and Materials Research,6( 2), 69-77,2014

A.A.Elhenawy, Chemistry and Materials Research,3 (12), 75-89, 2013

J.R.Vane, R.M. Botting, Mechanism of action of antiinflammatory drugs. Int. J. Tissue React., 20, 3-15,1998.

J.R.Vane, Y.S.Bakhle,; R.M. Botting, Cyclooxygenases 1 and 2. Annu. Rev. Pharmacol. Toxicol., 38, 97-120,1998.

D. Mukherjee, Selective cyclooxygenase-2 (COX-2) inhibitors and potential risk of cardiovascular events. Biochem. Pharmacol., 63, 817-821,2002.

J.R.Brown, R.N. DuBois, COX-2: a molecular target for colorectal cancer prevention. J. Clin. Oncol., 23, 2840-2855,2005.

C.E.Eberhart, R.J.Coffey, A.Radhika,; F.M.Giardiello, S.Ferrenbach, R.N. DuBois, Upregulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas. Gastroenterology 1994, 107, 1183-1188.

B.Rigas, I.S. Goldman, L.Levine, Altered eicosanoid levels in human colon cancer. J. Lab. Clin. Med., 122, 518-523,1993.

H.Sano, Y.Kawahito,R.L.Wilder, A.Hashiramoto, S. Mukai, K. Asai,. S.Kimura, H.Kato, M.Kondo, T.Hla, Expression of cyclooxygenase-1 and -2 in human colorectal cancer. Cancer Res., 55, 3785-3789,1995.

C.A. Guyton, J.E. Hall,

JR Vane, YS Bakhle, RM Botting.

M. Guslandi; (),"Gastric toxicity of antiplatelet therapy with low-dose aspirin", drugs.53,1-5,1997.

A.Maresca, C.Temperini, H. Vu, N. B.Pham,; S. A. Poulsen,; A. Scozzafa.; R. J.Quinn, C. T. Supuran, J. Am. Chem. Soc., 131, 3057,2009.

H.Vu, N. B. Pham, R. J. Quinn, J. Biomol. Screen., 13, 265,2008.

A.Maresca, C.Temperini, L.Pochet, B.Masereel, A.Scozzafava, C. T. Supuran, J. Med. Chem. 53, 335, 2010.

C. T. Supuran, Nat. Rev. Drug Disc. , 7, 168,2008

C. T. Supuran, A. Scozzafava, A. Casini, Development of sulfonamide carbonic anhydrase inhibitors (CAIs). In Carbonic Anhydrase

C. T. Supuran, Carbonic anhydrases as drug targets

J. Y.Winum, M. Rami, A.Scozzafava, J. L.Montero, C . Supuran, , Med. Res. Rev., 28, 445,2008.

C. T. Supuran, A. Scozzafava, A.Casini, Med. Res. Rev., 23, 146,2003.

W.R. Chegwidden, S.J.Dodgson, I.M. Spencer, ; EXS, 90, 343, 2000.

A. A. Elhenawy, Mona Sayed Kadh, Azza Radwan, Reda D. Abd-Elghany and M. K. Hassanein, J. Chem. Pharm. Res., , 7(12):1056-1066,2015.

Chen, P., Li, J., Ma, J., Teng, M., Li, X., Iubmb Life, 65, 518, 2013.

B.M. Nicol, S.B. Prasad. Ind. J Pharmacol ., 38(4), 260, 2006.

S.V Gothoskar, K.J Ranadive, Ind. J. Exp. Biol, 9, 372,1971.

M. A. El-Sayed, A. A. Shabaka, O. A. El-Shabrawy, N. A. Yassin, S.S. Mahmoud, S. M. El-Shenawy, E. Al-Ashqar, W.H. Eisa, N. M. Farag, M. A. El-Shaer, N. Salah, A. M. Al-Abd , PLOS ONE, 8(10), 2013.

J.J.P. Stewart., MOPAC Manual; (1993) Seventh Edition

G. R. Kurumbail, M. A. Stevens, K. J. Gierse, J. J. McDonald, A. R. Stegeman, Y. J. Pak, D. Gildehaus, M. J. Miyashiro, D. T. Penning, K. Seibert, C. P.Isakson, C. W. Stallings, " Structural basis for selective inhibition of cyclooxygenase-2 by anti-inflammatory agents " Nature 384, 644-648,1996.

J. R.Kiefer, J. L. Pawlitz, K. T. Moreland, R. A. Stegeman, W. F. Hood, J. K. Gierse, A. M. Steven, D. C. Goodwin, S. W. Rowlinson, L. J. Marnett, W.C. Stallings, R. G. Kurumbail.,

G. P. Hochgesang, L. J. Marnett,

Chemical Computing Group. Inc, MOE, 2015v.10.

T.A. Halgren.,

Y. Zhao, M.H. Abraham, J. Lee, A. Hersey, N.Ch. Luscombe, G. Beck, B. Sherborne, I. Cooper.,

Lipinski, C.A.; Lombardo, F.; Dominy, B.W.; Feeney, P.J.,

D.E. Clark, S.D. Pickett.,

S.A. Wildman, G.M. Crippen.,

K. Fukui,

W. B. Buck, G. D. Osweiter, A. G. Van Gelder, (1976) "Clinical and DiagnosticVeterinary Toxicology", 2nd ed., Kendall/Hunt Publishing Co., Iowa, p 5211.

R. Wiliheme, M. Gdynia., (1972)

Downloads

Published

2016-11-26

How to Cite

S. Kadah, M., Elhenawy, A. A., D. Abd , R., & Hassanein, M. K. (2016). Design and Synthesis of Novel NSAIDs Class Acting as Anticancer Agents. International Journal of Sciences: Basic and Applied Research (IJSBAR), 30(4), 32–52. Retrieved from https://www.gssrr.org/index.php/JournalOfBasicAndApplied/article/view/6573

Issue

Vol. 30 No. 4 (2016)

Section

Articles

License

Authors who submit papers with this journal agree to the following terms.